With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription ...

Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.

An economy expert says short term, senior citizens will continue to carry the high costs of prescription drugs. but President ...

Some have an immediate policy impact. Others are more symbolic. Some already are being challenged by federal lawsuits.

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

President Trump is rolling back Biden healthcare policies, such as expansions to the Affordable Care Act – a move Democrats ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

The Biden administration within days is expected to select the next batch of drugs that will be subject to Medicare price negotiations — a process that this time could include Novo Nordisk's ...

Because the cap was approved by Congress, it would take an act of Congress to overturn, but the incoming Trump ... with Medicare to cover prescription drugs also will absorb higher costs.